Total Funding
9
23
Total FundingDebt Financing raised
Growth Score
-14 pts
Heat Score
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
662908
Serometrix is a drug discovery company developing pharmaceutical drugs with a lower development cost.
Kyle Monroe: CEO
About the Company
Serometrix, LLC, a biotech drug discovery company, provides targeted lead stage molecules for preclinical drug development. The company offers Peptimer, a discovery platform, which identifies touch points critical to specific protein-protein interactions of interest. It provides its platform for oncology, cardiovascular, metabolic, CNS, and
infectious diseases. The company was founded in 2001 and is based in Pittsford, New York.
